<\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"}
}
, "answeringMemberConstituency" : {"_value" : "Warrington South"}
, "answeringMemberPrinted" : {"_value" : "David Mowat"}
, "dateOfAnswer" : {"_value" : "2016-09-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-09-19T13:28:31.287Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-09-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hospitals: Reorganisation"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to ensure that clinical commissioning groups consider the effect of hospital reconfigurations on (a) other health services, (b) pharmacies, (c) GPs and (d) ambulance services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"}
}
, "tablingMemberConstituency" : {"_value" : "Huddersfield"}
, "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"}
], "uin" : "46224"}
, {"_about" : "http://data.parliament.uk/resources/582532", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/582532/answer", "answerText" : {"_value" : "As part of NHS England\u2019s review of urgent and emergency care, the intention is to develop a clinical decision support system to enable patients to be directed to or connected with the right service to meet their needs, rather than being sent or taken to accident and emergency unless absolutely necessary.<\/p>
Commissioners, clinicians and the wider governance of urgent and emergency care have requested a next generation system that builds on the success of NHS Pathways but recognises the needs of individuals on the basis of the language they use, links to patient records and crisis plans and has the potential to factor in phenotypic data from wearables and remote monitoring devices.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1542", "label" : {"_value" : "Biography information for Philip Dunne"}
}
, "answeringMemberConstituency" : {"_value" : "Ludlow"}
, "answeringMemberPrinted" : {"_value" : "Mr Philip Dunne"}
, "dateOfAnswer" : {"_value" : "2016-09-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-09-21T08:20:15.29Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-09-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Standards"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to improve NHS triage systems.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"}
}
, "tablingMemberConstituency" : {"_value" : "Huddersfield"}
, "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"}
], "uin" : "46204"}
, {"_about" : "http://data.parliament.uk/resources/582533", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/582533/answer", "answerText" : {"_value" : "
NHS England released guidance to the local areas developing Sustainability and Transformation Plans (STPs) entitled \u2018Engaging local people\u2019 in September 2016 which can be found on their website. This guidance from NHS England to the STP Footprints highlights the need for public engagement and suggests ways of doing this.<\/p>
<\/p>
We expect that most areas will take a version of their STP to their organisation\u2019s public board meeting for discussion between late October and the end of the year. We would also expect that most areas will publish their plans, for more formal engagement, during this period. Every area will be working to a different timeframe, based on its own circumstances and how well-progressed its plan is.<\/p>
<\/p>
Proposals are at a draft stage but we expect all local leaders to be talking to the public and stakeholders regularly. It is vital that people are able to shape the future of their local services.<\/p>
<\/p>
No changes to the services people currently receive will be made without local engagement and, where required, consultation. There are longstanding assurance processes in place to make sure this happens.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"}
}
, "answeringMemberConstituency" : {"_value" : "Warrington South"}
, "answeringMemberPrinted" : {"_value" : "David Mowat"}
, "dateOfAnswer" : {"_value" : "2016-09-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-09-19T13:29:40.25Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-09-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Reorganisation"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to ensure that the concerns of local populations are taken into account in decisions about NHS Sustainability and Transformation Plans.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"}
}
, "tablingMemberConstituency" : {"_value" : "Huddersfield"}
, "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"}
], "uin" : "46187"}
, {"_about" : "http://data.parliament.uk/resources/582038", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/582038/answer", "answerText" : {"_value" : "
The Department receives numerous representations on prescription charges for people in England with long-term medical conditions. It is not possible to say how many of these were from clinical experts or health economists, though the independent Commission on the Future of Health and Social Care in England\u2019s report, A new settlement for health and social care, published in 2014, did have health economist input. There have also been representations from the Prescription Charges Coalition, but it is not certain to what extent these were informed by clinical experts or health economists.<\/p>
<\/p>
Arrangements are in place to ensure that prescriptions are affordable for everyone, including those with a long-term condition. There are exemptions from the prescription charge for people with low income, including through receipt of specific benefits and through application to the NHS Low Income Scheme. For those who do not qualify for exemption, prescription prepayment certificates are also available, which allow people to claim as many prescriptions as they need for a set cost. To support those with high levels of need, the cost of the 12-month and 3-month certificates have been frozen since 2009 and 2011, respectively.<\/p>
<\/p>
The Department has not undertaken a formal impact assessment on the potential cost of eliminating or reducing prescription charges for people with long-term medical conditions. However, the Prescription Charges Review undertaken by Professor Sir Ian Gilmore, and published in 2010, estimated that extending exemption to all those with a long-term condition would lead to a loss in revenue of between £360 and £430 million.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"}
}
, "answeringMemberConstituency" : {"_value" : "Warrington South"}
, "answeringMemberPrinted" : {"_value" : "David Mowat"}
, "dateOfAnswer" : {"_value" : "2016-09-15", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "45866"}
, {"_value" : "45877"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-09-15T12:31:46.27Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-09-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Chronic Illnesses: Prescriptions"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what representations he has received from clinical experts and health economists on prescription charges for people with long-term medical conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"}
}
, "tablingMemberConstituency" : {"_value" : "Huddersfield"}
, "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"}
], "uin" : "45865"}
, {"_about" : "http://data.parliament.uk/resources/582039", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/582039/answer", "answerText" : {"_value" : "
The Department receives numerous representations on prescription charges for people in England with long-term medical conditions. It is not possible to say how many of these were from clinical experts or health economists, though the independent Commission on the Future of Health and Social Care in England\u2019s report, A new settlement for health and social care, published in 2014, did have health economist input. There have also been representations from the Prescription Charges Coalition, but it is not certain to what extent these were informed by clinical experts or health economists.<\/p>
<\/p>
Arrangements are in place to ensure that prescriptions are affordable for everyone, including those with a long-term condition. There are exemptions from the prescription charge for people with low income, including through receipt of specific benefits and through application to the NHS Low Income Scheme. For those who do not qualify for exemption, prescription prepayment certificates are also available, which allow people to claim as many prescriptions as they need for a set cost. To support those with high levels of need, the cost of the 12-month and 3-month certificates have been frozen since 2009 and 2011, respectively.<\/p>
<\/p>
The Department has not undertaken a formal impact assessment on the potential cost of eliminating or reducing prescription charges for people with long-term medical conditions. However, the Prescription Charges Review undertaken by Professor Sir Ian Gilmore, and published in 2010, estimated that extending exemption to all those with a long-term condition would lead to a loss in revenue of between £360 and £430 million.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"}
}
, "answeringMemberConstituency" : {"_value" : "Warrington South"}
, "answeringMemberPrinted" : {"_value" : "David Mowat"}
, "dateOfAnswer" : {"_value" : "2016-09-15", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "45865"}
, {"_value" : "45877"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-09-15T12:31:46.347Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-09-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Chronic Illnesses: Prescriptions"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to ensure that prescriptions are affordable for people with long-term medical conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"}
}
, "tablingMemberConstituency" : {"_value" : "Huddersfield"}
, "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"}
], "uin" : "45866"}
, {"_about" : "http://data.parliament.uk/resources/582040", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/582040/answer", "answerText" : {"_value" : "
The Department receives numerous representations on prescription charges for people in England with long-term medical conditions. It is not possible to say how many of these were from clinical experts or health economists, though the independent Commission on the Future of Health and Social Care in England\u2019s report, A new settlement for health and social care, published in 2014, did have health economist input. There have also been representations from the Prescription Charges Coalition, but it is not certain to what extent these were informed by clinical experts or health economists.<\/p>
<\/p>
Arrangements are in place to ensure that prescriptions are affordable for everyone, including those with a long-term condition. There are exemptions from the prescription charge for people with low income, including through receipt of specific benefits and through application to the NHS Low Income Scheme. For those who do not qualify for exemption, prescription prepayment certificates are also available, which allow people to claim as many prescriptions as they need for a set cost. To support those with high levels of need, the cost of the 12-month and 3-month certificates have been frozen since 2009 and 2011, respectively.<\/p>
<\/p>
The Department has not undertaken a formal impact assessment on the potential cost of eliminating or reducing prescription charges for people with long-term medical conditions. However, the Prescription Charges Review undertaken by Professor Sir Ian Gilmore, and published in 2010, estimated that extending exemption to all those with a long-term condition would lead to a loss in revenue of between £360 and £430 million.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"}
}
, "answeringMemberConstituency" : {"_value" : "Warrington South"}
, "answeringMemberPrinted" : {"_value" : "David Mowat"}
, "dateOfAnswer" : {"_value" : "2016-09-15", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "45865"}
, {"_value" : "45866"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-09-15T12:31:46.41Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-09-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Chronic Illnesses: Prescriptions"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what impact assessment his Department has conducted on the potential cost of eliminating or reducing prescription charges for people with long-term medical conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"}
}
, "tablingMemberConstituency" : {"_value" : "Huddersfield"}
, "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"}
], "uin" : "45877"}
, {"_about" : "http://data.parliament.uk/resources/573459", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/573459/answer", "answerText" : {"_value" : "
Decisions are taken by NHS England\u2019s Specialised Commissioning Oversight Group that leads on the annual prioritisation process. The prioritisation process includes an impact assessment that compared the cost of a second transplant to alternative treatment pathways for relapsed disease.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"}
}
, "answeringMemberConstituency" : {"_value" : "Warrington South"}
, "answeringMemberPrinted" : {"_value" : "David Mowat"}
, "dateOfAnswer" : {"_value" : "2016-09-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-09-12T13:15:53.25Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-09-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Blood Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what estimate his Department has made of the financial saving to the NHS of the policy to no longer routinely fund second stem cell transplants for blood cancer patients who have relapsed.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/411", "label" : {"_value" : "Biography information for Mr Barry Sheerman"}
}
, "tablingMemberConstituency" : {"_value" : "Huddersfield"}
, "tablingMemberPrinted" : [{"_value" : "Mr Barry Sheerman"}
], "uin" : "44072"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_page=1&tablingMemberConstituency=Huddersfield&max-answer.questionFirstAnswered.=2016-09-21T08%3A20%3A15.29Z", "page" : 0, "startIndex" : 1, "totalResults" : 124, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}